eConsent in Healthcare Market Faces Integration and Compliance Challenges Despite Growth

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global eConsent In Healthcare Market - (By Platform (Cloud-based, Web-based), By Enrollment Type (On-Site, Remote), By Form Type (General Consent, General Consent with Specific Denial(S), General Denial with Specific Consent(S), General Denial)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."

According to the latest research by InsightAce Analytic, the Global eConsent In Healthcare Market is valued at USD 534.3 million in 2024, and it is expected to reach USD 1,211.8 million by the year 2034, with a CAGR of 9.3% during the forecast period of 2025-2034.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1866

Electronic consent (eConsent) refers to the digital methodology employed to obtain informed consent from patients within the healthcare industry. This approach leverages digital platforms-such as specialized software solutions and online interfaces-to deliver detailed, accessible information regarding medical procedures, treatments, surgeries, or other interventions, enabling patients to provide their consent electronically. The growing adoption of eConsent is being driven by its inherent benefits, including enhanced patient engagement, improved documentation accuracy, and streamlined administrative workflows, all of which align with the broader digital transformation across the healthcare sector.

Technological advancements and evolving regulatory frameworks that support the secure and compliant use of digital consent tools are further propelling market expansion. Additionally, modern eConsent platforms are increasingly being designed to accommodate the needs of diverse patient groups by offering personalized, user-friendly experiences. The industry's continued emphasis on operational efficiency and the reduction of manual processes is expected to sustain the upward trajectory of the global eConsent market.

List of Major Players in the EConsent In Healthcare Market:
• Florence Healthcare, Inc.
• ClinOne, Inc.
• Obvio Health USA, Inc.
• 5thPort, LLC
• Clinical Trials Arena
• EvidentIQ Group GmbH
• Definitive Healthcare, LLC
• Mednet Solutions, Inc.
• Delve Health, Inc.
• Magentus (formerly Citadel Health)
• ClinConsent, LLC
• Calysta EMR
• IQVIA Holdings Inc.
• RealTime Software Solutions, LLC
• Signant Health
• Kayentis
• Curebase, Inc.
• Advarra, Inc.
• Castor EDC, Inc.
• Dacima Software Inc.
• eClinicalHealth Limited
• Milo Healthcare
• Suvoda LLC
• DataRiver S.r.l.
• Jeeva Clinical Trials Inc.
• Y-Prime, LLC
• YonaLink
• OpenClinica, LLC
• Eclipse Clinical Technology, Inc.
• Thieme Compliance GmbH
• Crucial Data Solutions, Inc.
• Sitero, LLC
• ClinCapture, Inc.
• Medable, Inc.
• THREAD, Inc.
• Veeva Systems, Inc.
• Interlace Health (formerly FormFast)
• Climedo Health GmbH
• Medrio, Inc.
• Cloudbyz, Inc.
• Octalsoft (a part of Glorant, LLC USA)
• Medidata Solutions, Inc.
• EClinCloud (Shenzhen) Technology Co., Ltd
• Concentric Health Ltd
• Citadel Group Limited
• StudyKIK (a part of Syneos Health)
• Datacubed Health, Inc.
• ICON plc
• Clinical Ink, Inc.
• Wellbeing Software Group Ltd

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

Market Dynamics:
Drivers:
The growing implementation of electronic consent (eConsent) solutions within the healthcare sector is largely propelled by advancements in clinical research methodologies and medical innovation. Historically, the process of obtaining informed consent for clinical investigations relied heavily on manual documentation, often resulting in inefficiencies and administrative burden. eConsent introduces a modernized, secure, and efficient alternative that significantly improves the consent acquisition process. The increasing availability and use of mobile technologies have further enhanced the accessibility and convenience of digital consent tools, fostering greater engagement from both patients and healthcare professionals. As mobile device usage becomes more prevalent, the integration of eConsent systems is expected to accelerate.

Challenges:
Despite its benefits, the widespread adoption of eConsent is hindered by financial and technical barriers. Initial implementation costs can be substantial, influenced by the sophistication of the platform, the institution's financial resources, and the extent of customization required. These expenditures often encompass staff training, software acquisition, system integration, and compliance with regulatory standards. Furthermore, integrating automated consent documentation within existing healthcare infrastructure presents additional challenges, particularly with regard to data security and system interoperability.

Nonetheless, the COVID-19 pandemic has served as a catalyst for digital adoption, prompting healthcare providers to adopt remote consent solutions to maintain patient engagement during periods of restricted physical interaction. This shift has reinforced the need for digital transformation across healthcare settings, further promoting the adoption of eConsent technologies for surgeries, treatments, and clinical trials.

Regional Trends:
North America is anticipated to lead the global eConsent market in healthcare, driven by robust regulatory frameworks, technological innovation, the integration of electronic health records (EHRs), and a growing focus on patient-centric care models. The region's emphasis on advancing research and education, alongside the broader digitalization of healthcare services, supports this upward trend. Meanwhile, Europe is also demonstrating significant market growth, influenced by increasing chronic disease prevalence, expanding healthcare expenditure, and the growing incorporation of digital tools in medical research and patient care.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1866

Recent Developments:
• In Oct 2024, Mednet announced the release of their latest software, which includes electronic consent functionalities (eConsent) integrated within the iMednet eClinical platform. The newly developed eConsent module aims to offer a straightforward, economical, and compliant approach for gathering and storing participant consent, catering to the requirements of hybrid, virtual, and decentralized clinical trials, while also promoting enhanced participant diversity.

Segmentation of eConsent In Healthcare Market-
By Platform-
• Cloud-based
• Web-based
By Enrollment Type-
• On-Site
• Remote
By Form Type-
• General Consent
• General Consent with Specific Denial(S)
• General Denial with Specific Consent(S)
• General Denial
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/econsent-in-healthcare-market/1866

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.